Validation of a stability indicating LC-UV method for [(N-morpholine) methylene]daunorubicin hydrochloride

Chromatographia

Volumn 67, Issue SUPPL. 1, 2008, Pages

  Jelińska, Anna ^a   Zaja̧c, Marianna ^a   Cielecka Piontek, Judyta ^a   Gla̧b, Kinga ^a   Tomaszewicz, Bartosz ^a   Krause, Anna ^b   Oszczapowicz, Irena ^c   Wa̧sowska, Małgorzata ^c  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b GLAXOSMITHKLINE   (United Kingdom)

^c INDUSTRIAL CHEMISTRY RESEARCH INSTITUTE   (Poland)

Author keywords

(N Morpholine) methylene daunorubicin hydrochloride; Column liquid chromatography; Validation and stability

Indexed keywords

[(N MORPHOLINE)METHYLENE]DAUNORUBICIN; ACETONITRILE; DAUNORUBICIN DERIVATIVE; METHANOL; PHOSPHORIC ACID; PROTON; QUININE; SODIUM HYDROXIDE; WATER;

CONFERENCE PAPER; DRUG STABILITY; ENTHALPY; ENTROPY; FLOW RATE; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STANDARD; THERMODYNAMICS; ULTRAVIOLET RADIATION; VALIDATION STUDY;

EID: 43449095996     PISSN: 00095893     EISSN: 16121112     Source Type: Journal    
DOI: 10.1365/s10337-007-0512-3     Document Type: Conference Paper

References (22)

1. Arcamone F, Animati F, Capranico G, Lombardi P, Pratesi G, Manzini S, Supino R, Zunino F (1997) Pharmacol Ther 76:117-124
2. Hortobagyi BH (1997) Drugs 54(Suppl 4):1-7
3. Arola O, Saraste A, Pulki K, Kallajoki M, Parvinen M, Voipio-Pulkki L (2000) Cancer Res 60:1789-1792
4. Wa̧sowska M, Wietrzyk J, Opolski A, Oszczapowicz J, Oszczapowicbz I (2006) Cancer Res 26:2009-2012
5. Wa̧sowska M, Oszczapowicz I, Wietrzyk J, Polowski A (2001) In: 8th international symposium on molecular aspects of chemotherapy, Gdańsk, Poland
6. Opolska A, Wa̧sowska M, Wietrzyk J, Nasulewicz A, Oszczapowicz I, Oszczapowicz J (2002) In: 14th EORTC-NCI-AACr symposium on molecular targets and cancer therapeutics, Frankfurt, Germany
7. Wa̧sowska M, Opolski J, Wietrzyk J, Oszczapowicz I, Tobiasz J (2005) Joint meeting on medicinal chemistry, Vienna, Austria
8. Wa̧sowska M, Oszczapowicz I, Wietrzyk J, Opolski A, Madej J, Dzimira S, Oszczapowicz J (2005) Cancer Res 25:2043-2048
9. Nicholls G, Clark BJ, Brown JE (1992) J Pharm Biomed Anal 10:949-957
10. Rossi DT, Philips BA, Baldwin JR, Narang PK (1993) Anal Chim Acta 271:59-68
11. Barker IK, Crawford M, Tell A (1996) J Chromatogr B 681:323-329
12. Ricciarello R, Pichini S, Pacifici R, Altieri I, Pellegrini A, Faltorossi A, Zuccaro P (1998) J Chromatogr B 707:219-225
13. Kuhlmann O, Hofmann S, Weiss M (1999) J Chromatogr B 728:279-282
14. Lachatre F, Marquet P, Ragot S, Gaulier JM, Cardot P, Dupuy JL (2001) J Chromatogr B 738:281-291
15. Badea I, Lazar L, Moja D, Nicolescu D, Tudose A (2005) J Pharm Biomed Anal 39:305-309
16. Paim CS, Goncalves ML, Miron D, Sippel J, Steppe M (2007) Chromatographia 65:595-599
17. Beijnen J H, Houwen O, Voskuilen M, Unerberg W (1986) Inter J Pharm 31:75-82
18. Wassermann K, Bundgaard H (1983) Inter J Pharm 14:73-78
19. Wa̧sowska M, Oszczapowicz J, Oszczapowicz I, Owoc A (2005) Patent no. P. 378888
20. Commission of the European Community (1996) Validation of Analytical Procedures. In: Proceedings of the international conference on harmonisation (ICH)
21. Pawełczyk E, Hermann T (1982) The fundamentals of stability of drugs (in Poland), PZWL
22. Yoshioka S, Stella VJ (2002) Stability of drugs and dosage forms. Kluwer, Dordrecht